BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, today announced it has ...
BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent ...
INBRAIN Neuroelectronics Announces Collaboration to Advance Graphene-Based Brain-Computer Interfaces
INBRAIN to open Boston office to expand U.S. presence while maintaining headquarters in Barcelona, Spain As part of the collaboration, INBRAIN and Mayo Clinic experts will work together on a ...
BARCELONA, Spain, November 10, 2025--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the appointment of Scott Huennekens as Chairman of its ...
Elon Musk's Neuralink has a new competitor It's a startup company called Inbrain Neuroelectronics It says its chips are made of one of the strongest materials ever tested It aims to cure brain ...
INBRAIN Neuroelectronics, a Graphene Flagship spin-off company, has been named Spain’s most innovative company by leading Spanish news publication El Periódico. INBRAIN exists to decode and modulate ...
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath ...
INBRAIN Neuroelectronics is a spin-off company of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA. The company announces a €14.35M Series A investment, co-led by Asabys ...
Graphene-based BCI demonstrates high-resolution brain decoding and mapping in patients undergoing tumor resection at the Manchester Centre for Clinical Neurosciences Initial four patient cohort has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results